ロード中...
Clinical significance of plasmacytosis in the day+14 bone marrow of patients with acute myeloid leukaemia undergoing induction chemotherapy
BACKGROUND: The design of chemotherapy‐induction regimens for acute myeloid leukaemia (AML) is directed towards the early elimination of bone marrow (BM) leukaemic blast cells (LBCs). Patients with AML after induction show LBC reduction in a hypoplastic BM and also demonstrate a varying number of re...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1994521/ https://ncbi.nlm.nih.gov/pubmed/16731597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2005.032870 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|